TDC
AGN

Thompson Davis & Co’s Allergan plc AGN Stock Holding History

Thompson Davis & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-143
Closed -$29K – 1180
2017
Q3 		$29K Hold
143
– – 0.05% 364
2017
Q2 		$35K Buy
143
+54
+61% +$12.7K 0.06% 297
2017
Q1 		$21K Sell
89
-42
-32% -$9.78K 0.03% 483
2016
Q4 		$28K Sell
131
-268
-67% -$55.5K 0.05% 380
2016
Q3 		$92K Buy
399
+78
+24% +$19.1K 0.16% 150
2016
Q2 		$74K Buy
321
+58
+22% +$13.4K 0.12% 176
2016
Q1 		$70K Sell
263
-27
-9% -$7.73K 0.1% 197
2015
Q4 		$91K Sell
290
-112
-28% -$33.3K 0.13% 171
2015
Q3 		$109K Buy
402
+147
+58% +$45.2K 0.15% 153
2015
Q2 		$77K Sell
255
-1,500
-85% -$447K 0.09% 239
2015
Q1 		$522K Buy
1,755
+1,473
+522% +$420K 0.63% 24
2014
Q4 		$73K Buy
282
+115
+69% +$28.7K 0.08% 224
2014
Q3 		$40K Buy
+167
New +$37.4K 0.05% 311

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Thompson Davis & Co's AGN Position: Q4 2017 in Review

Thompson Davis & Co sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 143 shares — an estimated $29K sold.

Thompson Davis & Co first reported a position in AGN in Q3 2014 and held it in 13 quarters. The position peaked at $522K in Q1 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Thompson Davis & Co reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 143 Allergan plc shares in Q4 2017, an estimated $29K.
  • Thompson Davis & Co first reported a position in Allergan plc in Q3 2014 and held it in 13 quarters.
  • Thompson Davis & Co's Allergan plc position peaked at $522K in Q1 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.